Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients

Recruiting now · Phase 4 · Has a placebo group

Conditions studied: Critical Illness, New Onset Atrial Fibrillation

In brief

A double-blind, multi-centre, randomized, placebo-controlled, feasibility pilot trial in the prevention of new onset atrial fibrillation of critically ill patients admitted to an ICU.

Key facts

Study ID
NCT05829317
Run by
Dr. Stephanie Sibley
People needed
200
Starts
2023-08-20
Expected to finish
2028-07-01
Last updated by the study team
2025-09-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.